Welcome! Whether you are a potential investor in BioCryst Pharmaceuticals or you are already a shareholder, our investor center is the primary source of information about the company. Just choose a topic, or if you have a question, email us.
BioCryst and Idera Special Meetings to Be Held on July 10, 2018 New Clinical Data on Idera’s IMO-2125 Program Will Be Available Prior to Vote RESEARCH TRIANGLE PARK, N.C. & EXTON, Pa. --(BUSINESS WIRE)--Apr. 10, 2018-- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) (“BioCryst”) and Idera
BioCryst Mails Letter to Stockholders Highlighting Compelling Upside Opportunity BioCryst Special Meeting of Stockholders Scheduled for May 9, 2018 RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Apr. 2, 2018-- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) (“BioCryst”) today announced that it has
Questions about stock transfers and lost certificates should be directed to the transfer agent: American Stock Transfer & Trust Company
59 Maiden Lane
New York, NY 10038
1-800-937-5449 (toll free in US and Canada)
1-718-921-8200 (callers outside the US and Canada)